Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Zuzana Hľasová, Ivan Košík, Miroslav Ondrejovič, Stanislav Miertuš & Jaroslav Katrlík. (2019) Methods and Current Trends in Determination of Neuraminidase Activity and Evaluation of Neuraminidase Inhibitors. Critical Reviews in Analytical Chemistry 49:4, pages 350-367.
Read now
Read now
Li-Yan Zeng, Jie Yang & Shuwen Liu. (2017) Investigational hemagglutinin-targeted influenza virus inhibitors. Expert Opinion on Investigational Drugs 26:1, pages 63-73.
Read now
Read now
Viroj Wiwanitkit. (2015) Rates and effectiveness of antiviral use among hospitalized influenza patients. Expert Review of Anti-infective Therapy 13:7, pages 835-842.
Read now
Read now
Young June Choe, Hyunju Lee, Hoan Jong Lee & Eun Hwa Choi. (2015) Antiviral treatment of influenza in South Korea. Expert Review of Anti-infective Therapy 13:6, pages 741-749.
Read now
Read now
Alexandre Monod, Christopher Swale, Bogdan Tarus, Alice Tissot, Bernard Delmas, Rob Wh Ruigrok, Thibaut Crépin & Anny Slama-Schwok. (2015) Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenza. Expert Opinion on Drug Discovery 10:4, pages 345-371.
Read now
Read now
Articles from other publishers (41)
Dilipkumar Pal, Kamal Bareth, Priyanka Rani, Chandi Charan Kandar & Abhishek Mishra. 2024. Anti-Viral Metabolites from Medicinal Plants. Anti-Viral Metabolites from Medicinal Plants
1039
1065
.
Kuanglei Wang, Huicong Zhang & Yongshou Tian. (2022) The current strategies of optimization of oseltamivir against mutant neuraminidases of influenza A：A review. European Journal of Medicinal Chemistry 243, pages 114711.
Crossref
Crossref
Yuhong Fu, Peiyu Li, Wei Xu, Zezhong Liu, Cong Wang, Qian Wang, Jiayi Tang, Weihua Li, Lu Lu & Shibo Jiang. (2022) Chemically Modified Bovine β-Lactoglobulin as a Broad-Spectrum Influenza Virus Entry Inhibitor with the Potential to Combat Influenza Outbreaks. Viruses 14:9, pages 2055.
Crossref
Crossref
Amalia Di Petrillo, Germano Orrù, Antonella Fais & Massimo C. Fantini. (2021) Quercetin and its derivates as antiviral potentials: A comprehensive review. Phytotherapy Research 36:1, pages 266-278.
Crossref
Crossref
Hongqian Zhao, Siyuan Jiang, Zhifan Ye, Hongxi Zhu, Baichun Hu, Peipei Meng, Yanmei Hu, Huicong Zhang, Kuanglei Wang, Jun Wang & Yongshou Tian. (2021) Discovery of hydrazide-containing oseltamivir analogues as potent inhibitors of influenza A neuraminidase. European Journal of Medicinal Chemistry 221, pages 113567.
Crossref
Crossref
Jie Yang, Bei Zhang, Yingna Huang, Teng Liu, Baishuang Zeng, Jinwei Chai, Jiena Wu & Xueqing Xu. (2021)
Antiviral activity and mechanism of ESC-1GN from skin secretion of
Hylarana guentheri
against influenza A virus
. The Journal of Biochemistry 169:6, pages 757-765.
Crossref
Crossref
Wei Ai, Jian Zhang, Waleed A. Zalloum, Ruifang Jia, Srinivasulu Cherukupalli, Xiao Ding, Zhuosen Sun, Lin Sun, Xiangyi Jiang, Xiuli Ma, Zhong Li, Defeng Wang, Bing Huang, Peng Zhan & Xinyong Liu. (2020) Discovery of novel “Dual-site” binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors. European Journal of Medicinal Chemistry 191, pages 112147.
Crossref
Crossref
Shruti Mishra, Achyut Pandey & Siddharth Manvati. (2020) Coumarin: An emerging antiviral agent. Heliyon 6:1, pages e03217.
Crossref
Crossref
Kuanglei Wang, Zaiqiang Lei, Lei Zhao, Binfeng Chen, Fei Yang, Kemin Liu, Hongxi Zhu, Hongqian Zhao, Ruiyuan Cao, Kun Zhang & Yongshou Tian. (2020) Design, synthesis and biological evaluation of oseltamivir derivatives containing pyridyl group as potent inhibitors of neuraminidase for influenza A. European Journal of Medicinal Chemistry 185, pages 111841.
Crossref
Crossref
Ryan C. Maves. 2020. Principles and Practice of Maternal Critical Care. Principles and Practice of Maternal Critical Care
231
242
.
Ruifang Jia, Jian Zhang, Wei Ai, Xiao Ding, Samuel Desta, Lin Sun, Zhuosen Sun, Xiuli Ma, Zhong Li, Defeng Wang, Bing Huang, Peng Zhan & Xinyong Liu. (2019) Design, synthesis and biological evaluation of “Multi-Site”-binding influenza virus neuraminidase inhibitors. European Journal of Medicinal Chemistry 178, pages 64-80.
Crossref
Crossref
Zhang, Xu, Zhang, Liu, Xue & Cao. (2019) Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus. Viruses 11:5, pages 405.
Crossref
Crossref
Mohui Wei & Peng George Wang. 2019. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A
25
57
.
Erik A. Karlsson, J. Justin Milner, William D. Green, Jennifer Rebeles, Stacey Schultz-Cherry & Melinda A. Beck. 2019. Mechanisms and Manifestations of Obesity in Lung Disease. Mechanisms and Manifestations of Obesity in Lung Disease
227
259
.
Ganuskh Enkhtaivan, Doo Hwan Kim, Gyun Seok Park, Muthuraman Pandurangan, Daniel A. Nicholas, So Hyun Moon, Avinash A. Kadam, Rahul V. Patel, Han-Seung Shin & Bhupendra M. Mistry. (2018) Berberine-piperazine conjugates as potent influenza neuraminidase blocker. International Journal of Biological Macromolecules 119, pages 1204-1210.
Crossref
Crossref
Enkhtaivan Gansukh, Vimala Anthonydhason, Somang Jung, Doo Hwan Kim, Manikandan Muthu, Judy Gopal & Sechul Chun. (2018) Nanotherapeutic Anti-influenza Solutions: Current Knowledge and Future Challenges. Journal of Cluster Science 29:6, pages 933-941.
Crossref
Crossref
Urmi Patel, Aaron Gingerich, Lauren Widman, Demba Sarr, Ralph A. Tripp & Balázs Rada. (2018) Susceptibility of influenza viruses to hypothiocyanite and hypoiodite produced by lactoperoxidase in a cell-free system. PLOS ONE 13:7, pages e0199167.
Crossref
Crossref
Han Sol Lee, Ji Yun Noh, Joon Young Song, Hee Jin Cheong, Won Suk Choi, Hye Won Jeong, Seong-Heon Wie & Woo Joo Kim. (2018) Molecular genetic characteristics of influenza A virus clinically isolated during 2011-2016 influenza seasons in Korea. Influenza and Other Respiratory Viruses 12:4, pages 497-507.
Crossref
Crossref
Urai Chaisri & Wanpen Chaicumpa. (2018) Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy. BioMed Research International 2018, pages 1-23.
Crossref
Crossref
Hou-Wen Cheng, Hsiao-Wen Wang, Tsung-Yun Wong, Hsien-Wei Yeh, Yi-Chun Chen, Der-Zen Liu & Pi-Hui Liang. (2018) Synthesis of S-linked NeuAc-α(2-6)-di-LacNAc bearing liposomes for H1N1 influenza virus inhibition assays. Bioorganic & Medicinal Chemistry 26:9, pages 2262-2270.
Crossref
Crossref
Lucas Deecke & Hana M. Dobrovolny. (2018) Intermittent treatment of severe influenza. Journal of Theoretical Biology 442, pages 129-138.
Crossref
Crossref
Dominik M. Meinel, Susanne Heinzinger, Ute Eberle, Nikolaus Ackermann, Katharina Schönberger & Andreas Sing. (2017) Whole genome sequencing identifies influenza A H3N2 transmission and offers superior resolution to classical typing methods. Infection 46:1, pages 69-76.
Crossref
Crossref
Karoline Droebner, Emanuel Haasbach, Sabine E. Dudek, Gerhard Scheuch, Karlheinz Nocker, Sebastian Canisius, Christina Ehrhardt, Georges von Degenfeld, Stephan Ludwig & Oliver Planz. (2017) Pharmacodynamics, Pharmacokinetics, and Antiviral Activity of BAY 81-8781, a Novel NF-κB Inhibiting Anti-influenza Drug. Frontiers in Microbiology 8.
Crossref
Crossref
Ing-Chien Chen, Yi-Kai Chiu, Chung-Ming Yu, Cheng-Chung Lee, Chao-Ping Tung, Yueh-Liang Tsou, Yi-Jen Huang, Chia-Lung Lin, Hong-Sen Chen, Andrew H.-J. Wang & An-Suei Yang. (2017) High throughput discovery of influenza virus neutralizing antibodies from phage-displayed synthetic antibody libraries. Scientific Reports 7:1.
Crossref
Crossref
Jung Shim, Jinhee Kim, Tanel Tenson, Ji-Young Min & Denis Kainov. (2017) Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis. Viruses 9:8, pages 223.
Crossref
Crossref
Ahmed N. Alghamdi, Mohammad E. Mahfouz, Fahd A. Hamdi, Daifullah Al Aboud, Tawfiq Z. Al-laylah, Mohammed I. Alotaibi, Khalid W.A. Al-Thomali & Ahmed S. Abdel-Moneim. (2017) Sequence analysis of haemagglutinin and neuraminidase of H1N1 strain from a patient coinfected with Mycobacterium tuberculosis. Molecular and Cellular Probes 34, pages 59-63.
Crossref
Crossref
Tatyana M. Khomenko, Vladimir V. Zarubaev, Iana R. Orshanskaya, Renata A. Kadyrova, Victoria A. Sannikova, Dina V. Korchagina, Konstantin P. Volcho & Nariman F. Salakhutdinov. (2017) Anti-influenza activity of monoterpene-containing substituted coumarins. Bioorganic & Medicinal Chemistry Letters 27:13, pages 2920-2925.
Crossref
Crossref
Enkhtaivan Gansukh, Manikandan Muthu, Diby Paul, Gopal Ethiraj, Sechul Chun & Judy Gopal. (2017) Nature nominee quercetin's anti-influenza combat strategy-Demonstrations and remonstrations. Reviews in Medical Virology 27:3, pages e1930.
Crossref
Crossref
M. Goeijenbier, P. van Genderen, B. J. Ward, A. Wilder-Smith, R. Steffen & A. D. M. E. Osterhaus. (2017) Travellers and influenza: risks and prevention. Journal of Travel Medicine 24:1, pages taw078.
Crossref
Crossref
Ralph Tripp & Jarod Hanson. 2016. Advances in Pulmonary Drug Delivery. Advances in Pulmonary Drug Delivery
93
130
.
Amy Y. Chang, Tracy S. Mann, Peter K. McFawn, Liang Han, Xinzhong Dong & Peter J. Henry. (2016) Investigating the role of MRGPRC11 and capsaicin-sensitive afferent nerves in the anti-influenza effects exerted by SLIGRL-amide in murine airways. Respiratory Research 17:1.
Crossref
Crossref
Pedro Laborda, Su-Yan Wang & Josef Voglmeir. (2016) Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological Activity. Molecules 21:11, pages 1513.
Crossref
Crossref
Charlene Ranadheera, Mable W. Hagan, Anders Leung, Brad Collignon, Todd Cutts, Steven Theriault, Carissa Embury-Hyatt & Darwyn Kobasa. (2016) Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice. Journal of Virology 90:21, pages 9931-9941.
Crossref
Crossref
Sandra Söderholm, Denis E. Kainov, Tiina Öhman, Oxana V. Denisova, Bert Schepens, Evgeny Kulesskiy, Susumu Y. Imanishi, Garry Corthals, Petteri Hintsanen, Tero Aittokallio, Xavier Saelens, Sampsa Matikainen & Tuula A. Nyman. (2016) Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human Macrophages. Molecular & Cellular Proteomics 15:10, pages 3203-3219.
Crossref
Crossref
Sandra Söderholm, Yu Fu, Lana Gaelings, Sergey Belanov, Laxman Yetukuri, Mikhail Berlinkov, Anton Cheltsov, Simon Anders, Tero Aittokallio, Tuula Nyman, Sampsa Matikainen & Denis Kainov. (2016) Multi-Omics Studies towards Novel Modulators of Influenza A Virus–Host Interaction. Viruses 8:10, pages 269.
Crossref
Crossref
Kelly M. Thayer. (2016) Structure prediction and analysis of neuraminidase sequence variants. Biochemistry and Molecular Biology Education 44:4, pages 361-376.
Crossref
Crossref
Karla D. Passalacqua, Marie-Eve Charbonneau, Nicholas J. Donato, Hollis D. Showalter, Duxin Sun, Bo Wen, Miao He, Hanshi Sun, Mary X. D. O'Riordan & Christiane E. Wobus. (2016) Anti-infective Activity of 2-Cyano-3-Acrylamide Inhibitors with Improved Drug-Like Properties against Two Intracellular Pathogens. Antimicrobial Agents and Chemotherapy 60:7, pages 4183-4196.
Crossref
Crossref
Ning Chai, Lee R. Swem, Mike Reichelt, Haiyin Chen-Harris, Elizabeth Luis, Summer Park, Ashley Fouts, Patrick Lupardus, Thomas D. Wu, Olga Li, Jacqueline McBride, Michael Lawrence, Min Xu & Man-Wah Tan. (2016) Two Escape Mechanisms of Influenza A Virus to a Broadly Neutralizing Stalk-Binding Antibody. PLOS Pathogens 12:6, pages e1005702.
Crossref
Crossref
Wenwen Lian, Jiansong Fang, Chao Li, Xiaocong Pang, Ai-Lin Liu & Guan-Hua Du. (2015) Discovery of Influenza A virus neuraminidase inhibitors using support vector machine and Naïve Bayesian models. Molecular Diversity 20:2, pages 439-451.
Crossref
Crossref
Wenjiao Wu, Richan Li, Xianglian Li, Jian He, Shibo Jiang, Shuwen Liu & Jie Yang. (2015) Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry. Viruses 8:1, pages 6.
Crossref
Crossref
Karthik Viswanathan, Zachary Shriver & Gregory J. Babcock. (2015) Amino acid interaction networks provide a new lens for therapeutic antibody discovery and anti-viral drug optimization. Current Opinion in Virology 11, pages 122-129.
Crossref
Crossref